Soligenix begins confirmatory phase 3 trial of HyBryte for treatment of cutaneous T-cell lymphoma: Princeton, New Jersey Wednesday, December 18, 2024, 14:00 Hrs [IST] Soligenix, I ...

Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, ...

(Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, ...

Earlier this year, scientists stumbled upon a potential new treatment for hereditary-patterned baldness, the most common ...

City of Hope® Research Spotlight offers a glimpse at groundbreaking scientific and clinical discoveries advancing lifesaving ...

Researchers accidentally discovered a potential hair loss treatment while studying wound healing in mice. Applying ...

When it comes to clearing up your eyebrow dandruff, the right approach depends on what’s causing your shedding in the first ...

Mouth ulcers will usually resolve on their own, but there are some things you can do to help relieve the pain. Dr. Gonchar ...

Led by Aliyu Tetengi Ibrahim and his team at Ahmadu Bello University, a study published in Data Science and Management on ...

21, 2024 — Hidradenitis suppurativa (HS) is an immune disease that affects up to 4% of the global population and causes painful, recurring skin lesions ... Patch for Treatment of Psoriasis ...